New forms of torture leave ‘invisible scars’, say researchers

  London, UK (December 31, 2011) – Use of torture around the world has not diminished but the techniques used have grown more complex and sophisticated, according to new research from Queen Mary, University of London. The study suggests that these emerging forms of torture, which include various types of rape, bestiality and witnessing violent
WEITERLESEN »

FDA and CDC Update: Investigation of Cronobacter bacteria illness in infants

  Silver Spring, Maryland / Atlanta, Georgia (December 30, 2011) – The Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC) and state health departments continue to investigate four recent cases of Cronobacter infection in infants in four states: Florida, Illinois, Missouri, and Oklahoma. There is currently no evidence that indicates
WEITERLESEN »

HIV study named 2011 breakthrough of the year by Science

  Bethesda, MD, USA (December 22, 2011) – The journal Science has chosen the HPTN 052 clinical trial (http://www.niaid.nih.gov/news/newsreleases/2011/Pages/HPTN052.aspx), an international HIV prevention trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, as the 2011 Breakthrough of the Year. The study found that if HIV-infected
WEITERLESEN »

European Medicines Agency starts review of aliskiren-containing medicines following termination of ALTITUDE study

  London, UK (December 22, 2011) – The European Medicines Agency is reviewing aliskiren-containing medicines, to assess the impact of data coming from the ALTITUDE study on the balance of benefits and risks of these medicines in their approved indication.  

Researcher contends multiple sclerosis is not a disease of the immune system

  Chicago, Ill., USA (December 22, 2011) – An article to be published Friday (Dec. 23) in the December 2011 issue of The Quarterly Review of Biology argues that multiple sclerosis, long viewed as primarily an autoimmune disease, is not actually a disease of the immune system. Dr. Angelique Corthals, a forensic anthropologist and professor
WEITERLESEN »

Statement on the NSABB Review of H5N1 Research

  Bethesda, Maryland, USA (December 20, 2011) – The U.S. government remains concerned about the threat of influenza, for the risks it poses seasonally, as well as its potential to cause a pandemic. Our domestic and global influenza surveillance efforts have become increasingly capable, along with expanded vaccine manufacturing capacity and assistance to other countries
WEITERLESEN »

European Medicines Agency recommends approval of first-in-class treatment for metastatic or unresectable melanoma

  London, UK (December 16, 2011) – The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the granting of a marketing authorisation for a novel protein-kinase inhibitor to treat patients suffering from metastatic or unresectable melanoma with BRAF V600 mutations.  

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 December 2011

  London, UK (December 16, 2011) – This page lists the opinions adopted at the December 2011 meeting of the Committee for Medicinal Products for Human Use (CHMP) and other important outcomes.  

European Medicines Agency to continue to involve patients in scientific discussions on human medicines

  London, UK (December 15, 2011) – The European Medicines Agency’s pilot of involving patient representatives in scientific advisory group (SAG) meetings has been successful, according to the outcome report published today.  

European Medicines Agency confirms positive benefit-risk balance of somatropin-containing medicines

  London, United Kingdom (December 15,2011) – Finalising its review of somatropin-containing medicines, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) confirms that the benefit-risk balance of these medicines remains positive. However, the CHMP wished to remind prescribers to strictly follow the approved indications and doses and to carefully consider the
WEITERLESEN »

Researchers investigate link between autoimmune diseases and wounds that don’t heal

  Washington, DC (December 15, 2011) – Millions of Americans suffer from wounds that don’t heal, and while most are typically associated with diabetes, new research has identified another possible underlying cause – autoimmune diseases. The finding, published online Dec. 14th in the International Wound Journal, represents an unappreciated link that could lead to important
WEITERLESEN »

Researchers identify phthalates in numeruous medicines and supplements

  Boston, Massachusetts, USA (December 15, 2011) – Researchers from Boston University’s Slone Epidemiology Center (SEC), in collaboration with Harvard School of Public Health, have found numerous prescription and over-the-counter drugs and supplements use certain chemicals called phthalates as inactive ingredients in their products. The findings appear on-line in Environmental Health Perspectives.  

Sexual Violence, Stalking, and Intimate Partner Violence Widespread in the US

  Atlanta, GA, USA (December 14, 2011) – On average, 24 people per minute are victims of rape, physical violence, or stalking by an intimate partner in the United States, according to findings released today by the Centers for Disease Control and Prevention. Over the course of a year, that equals more than 12 million
WEITERLESEN »

Committee for Orphan Medicinal Products (COMP) December highlights

  London, United Kingdom (December 13, 2011) – During its December 2011 meeting, the Committee for Orphan Medicinal Products (COMP) recommended granting orphan designation for nine substances.  

To keep nurses, improve their work environments

  Philadelphia, PA, USA (December 8, 2011) – Nurses working in hospitals around the world are reporting they are burned out and dissatisfied with their jobs, reported researchers at the University of Pennsylvania School of Nursing’s Center for Health Outcomes and Policy Research in a study of 100,000 nurses in nine countries.  

Chronic pain in children and adolescents becoming more common

  Philadelphia, PA, USA (December 8, 2011) – Children who suffer from persistent or recurring chronic pain may miss school, withdraw from social activities, and are at risk of developing internalizing symptoms such as anxiety, in response to their pain. In the first comprehensive review of chronic pain in children and adolescents in 20 years,
WEITERLESEN »

CDC Issues Recommendations on Use of New Treatment Option for Latent TB Infection

  Atlanta, GA, USA (December 8, 2011) – Health care providers in the United States have a new way to treat latent tuberculosis infection, according to recommendations released today by the Centers for Disease Control and Prevention. The new recommendations, published today in CDC’s Morbidity and Mortality Weekly Report, provide guidance on how to administer
WEITERLESEN »

Few hospitals aggressively combat catheter-associated urinary tract infections

Ann Arbour, Mich., USA (December 8, 2011) – Hospitals are working harder than ever to prevent hospital-acquired infections, but a nationwide survey shows few are aggressively combating the most common one – catheter-associated urinary tract infections.

2 out of 3 medical students do not know when to wash their hands

  Washington, DC, USA (December 1, 2011) – Only 21 percent of surveyed medical students could identify five true and two false indications of when and when not to wash their hands in the clinical setting, according to a study published in the December issue of the American Journal of Infection Control, the official publication
WEITERLESEN »

Improving patient care by improving nurses‘ work environment

  New York, NY, USA (November 30, 2011) – While nurse-to-patient ratios are widely recognized as an important factor in determining the quality of patient care, those ratios are not always easy to change without significant cost and investment of resources. What’s more, the projected nursing shortage will make it even more difficult for hospitals
WEITERLESEN »

Low Staffing and Poor Quality of Care at Nation’s For-Profit Nursing Homes

  San Francisco (November 29, 2011) – The nation’s largest for-profit nursing homes deliver significantly lower quality of care because they typically have fewer staff nurses than non-profit and government-owned nursing homes. That’s the finding of a new UCSF-led analysis of quality of care at nursing homes around the country. It is the first-ever study
WEITERLESEN »

Can you feel her Pain? „I can’t go to work now because sitting down is worse than standing up“

    She was a practising barrister in Dublin when she was hit from behind by a truck. What started off as numbness around the roof of her mouth would end up with Gina suffering from severe chronic pain: “I felt as though my fingers were stuck in an electric socket and the electricity was
WEITERLESEN »

Pain Alliance Europe – New Alliance to lobby for 100 million Chronic Pain patients

  Brussels, Belgium (November 29, 2011) – In the presence of several MEPs from major political parties, a representative from the Commission and the President of EFIC, the health pofessionals´ pan-European organisation on pain research, Pain Alliance Europe (PAE) was officially launched in the European Parliament. The aim of the new Patients´ Alliance – a
WEITERLESEN »

Elderly at risk of hospitalizations from key medications

  Atlanta, GA, USA (November 23, 2011) – Each year, there are nearly 100,000 emergency hospitalizations for adverse drug events in U.S. adults aged 65 years or older, according to a Centers for Disease Control and Prevention study published today in the New England Journal of Medicine . Of the thousands of medications available to
WEITERLESEN »

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 November 2011

  London, UK (November 18, 2011) – This page lists the opinions adopted at the November 2011 meeting of the Committee for Medicinal Products for Human Use (CHMP) and other important outcomes.  

Fatigue linked to safety problems among EMS workers

  Pittsburgh, Pennsylvania, USA (November 17, 2011) – Fatigue and poor sleep quality, which affect many emergency medical services (EMS) workers, are linked to higher reported rates of injuries, medical errors and safety-compromising behaviors, according to a study by University of Pittsburgh researchers that is now available online in Prehospital Emergency Care and appearing in
WEITERLESEN »

Training in ‚concrete thinking‘ can be self-help treatment for depression

  Exeter, Devon, UK (November 17, 2011) – The study suggests an innovative psychological treatment called ‚concreteness training‘ can reduce depression in just two months and could work as a self-help therapy for depression in primary care. Led by the University of Exeter and funded by the Medical Research Council, the research shows how this
WEITERLESEN »

Worms reveal secrets of wound-healing response

  San Diego, California, USA (November 17, 2011) – The lowly and simple roundworm may be the ideal laboratory model to learn more about the complex processes involved in repairing wounds and could eventually allow scientists to improve the body’s response to healing skin wounds, a serious problem in diabetics and the elderly.  

Presenteeism: A new word for working when sick

  Montreal, Canada (November 17, 2011) – Colleagues who work with runny noses, sore throats and clammy skin are as seasonal as the flu. Yet are sick employees workplace troopers or are they insecure about their jobs? A new study from Concordia University, published in the Journal of Occupational Health Psychology, has found that presenteeism,
WEITERLESEN »

European Medicines Agency recommends suspension of all buflomedil-containing medicines

  London, UK (November 17, 2011) – The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) concluded a review of the safety and efficacy of buflomedil, saying that the risks of these medicines, particularly the risks of severe cardiological and neurological adverse reactions, are greater than their limited benefits in the treatment
WEITERLESEN »

CDC now tracking antibiotic use in hospitals

  Atlanta, GA, USA (November 14, 2011) – The Centers for Disease Control and Prevention is launching a new antibiotic tracking system allowing hospitals to monitor antibiotic use electronically, make better decisions about how to improve use, and compare themselves to other hospitals. Before now, CDC was only able to track antibiotic use in doctors′
WEITERLESEN »

MSD (Europe) withdraws its marketing authorisation application for Janacti (sitagliptin and pioglitazone)

  London, UK, (November 14, 2011) – The European Medicines Agency has been formally notified by Merck Sharp & Dohme (Europe), Inc. of its decision to withdraw its application for a centralised marketing authorisation for the medicine Janacti (sitagliptin and pioglitazone) and related trade names, 100/30 mg and 100/45 mg fixed-dose combination tablets. Janacti was
WEITERLESEN »

New study shows smokers underutilize proven treatment and services for quitting

  Atlanta, GA, USA (November 10, 2011) – Most American adults who smoke wish they could quit, and more than half have tried within the past year, according to a report by the Centers for Disease Control and Prevention. The report says 68.8 percent of current American adult smokers say they want to quit and
WEITERLESEN »

Groundbreaking study finds home treatment of pneumonia better than hospital care

  Boston, Newengland, USA (November 10, 2011) — In a breakthrough study published online today in The Lancet, researchers from Boston University, Save the Children and the WHO found that young children treated at home for severe pneumonia by Pakistan’s network of "lady health workers" were more likely to get well than children referred to
WEITERLESEN »

New study challenges accepted approaches to research in senile dementia (Alzheimer’s disease)

  Amsterdam, NL (7. November 2011) – Impacting millions of families and devouring billions of dollars globally, Alzheimer’s disease is the focus of exhaustive research to find a cure. Although intensely investigated over the last three decades using cutting-edge technologies, the "pathogenic cause" of Alzheimer’s disease has not been found. While many research "breakthroughs" have
WEITERLESEN »

Nutritional intervention helps in mild Alzheimer’s disease

  San Diego, CA, USA (November 4, 2011) – A second clinical trial of the medical food Souvenaid confirmed that daily intake of the nutritional intervention improves memory in people with mild Alzheimer’s disease (AD). Results of the trial – called Souvenir II – were presented at the 4th International Conference on Clinical Trials in
WEITERLESEN »

Nurses’ Perceptions of Error Reporting and Disclosure in Nursing Homes

  New York, NY, USA (November 4, 2011) – Nurses have an obligation to disclose an error when one occurs. While errors should be avoided as much as possible, the reality is the health care delivery system is not and will never be perfect; errors and adverse events are an inevitable part of care.  

How We Create False Memories: Assessing Memory Performance in Older Adults

  Washington, DC (November 4, 2011) – A new study in Psychological Science, a journal of the Association for Psychological Science, published online October 26 addresses the influence of age-related stereotypes on memory performance and memory errors in older adults.  

Nurse practiotioner reduces unnecessary emergency department visits

  Maywood, Ill., USA (November 4, 2011) – Adding a nurse practitioner (NP) to a busy hospital staff can decrease unnecessary emergency department (ED) visits, according to a study published in the latest issue of Surgery by researchers at Loyola University Health System. Researchers found that the nurse practitioner reduced ED visits by improving the
WEITERLESEN »

Latex gloves lead to lax hand hygiene in hospitals, study finds

  Chicago, Ill., USA (November 3, 2011) – Healthcare workers who wear gloves while treating patients are much less likely to clean their hands before and after patient contact, according to a study published in the December issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America. This
WEITERLESEN »

Researchers find anti-depressants reduce pain in opioid-dependent patients

  Boston, Massachusetts, USA (November 3, 2011) – In what is believed to be the first study of its kind to demonstrate an association between the antidepressant escitalopram and improved general pain, researchers from Boston University School of Medicine (BUSM), have found that opioid-dependent patients treated with escitalopram experienced meaningful reductions in pain severity and
WEITERLESEN »

Dirt prevents allergy

  Copenhagen, Denmark (November 2, 2011) – If infants encounter a wide range of bacteria they are less at risk of developing allergic disease later in life. This is the conclusion of research from the University of Copenhagen, which suggests completely new factors in many modern lifestyle diseases.  

Prescription painkiller overdoses at epidemic levels

  Atlanta, GA, USA (November 1, 2011) – The death toll from overdoses of prescription painkillers has more than tripled in the past decade, according to an analysis in the CDC Vital Signs report released today from the Centers for Disease Control and Prevention. This new finding shows that more than 40 people die every
WEITERLESEN »

EMA: Assessment templates updated to include information on geriatric studies and new active substance claims

  London, United Kingdom (October 28, 2011) – The European Medicines Agency has updated its templates for assessment reports on human medicines to include information on how medicines were studied in the elderly and on claims that a medicine contains a new active substance.  

Scientists prove regular aspirin intake halves cancer risk

  Belfast, United Kingdom (October 28, 2011) – Scientists including those from Queen’s University have discovered that taking regular aspirin halves the risk of developing hereditary cancers.   Hereditary cancers are those which develop as a result of a gene fault inherited from a parent. Bowel and womb cancers are the most common forms of hereditary
WEITERLESEN »

CDC recommends ways to reduce the threat of strokes

  Atlanta, GA, USA (October 27, 2011) – In the time needed to read out loud the headline on this story, someone has died from a stroke. Every 6 seconds, someone in the world dies from stroke. The Centers for Disease Control and Prevention, in support of World Stroke Day, Oct. 29, 2011, asks Americans
WEITERLESEN »

Children suffer unnecessarily from chronic postoperative pain

  Irvine, California (October 27, 2011) — Are children suffering needlessly after surgery? UC Irvine anesthesiologists who specialize in pediatric care believe so. An operation can be one of the most traumatic events children face, and according to a UCI study, many of them experience unnecessary postsurgical pain lasting weeks or months.  

Religious, spiritual support benefits men and women facing chronic illness

  Columbia, Mo., USA (October 26, 2011) – Individuals who practice religion and spirituality report better physical and mental health than those who do not. To better understand this relationship and how spirituality/religion can be used for coping with significant health issues, University of Missouri researchers are examining what aspects of religion are most beneficial
WEITERLESEN »

Advance toward a breath test to diagnose multiple sclerosis

  Washington, DC, USA (October 26, 2011) – Scientists are reporting the development and successful tests in humans of a sensor array that can diagnose multiple sclerosis (MS) from exhaled breath, an advance that they describe as a landmark in the long search for a fast, inexpensive and non-invasive test for MS — the most
WEITERLESEN »

Xigris (drotrecogin alfa (activated)) to be withdrawn due to lack of efficacy

  London, United Kingdom (October 25, 2011) – The European Medicines Agency has been informed of Eli Lilly’s decision to withdraw Xigris from the market worldwide further to the 28-day mortality results from the PROWESS-SHOCK study. Eli Lilly has also decided to discontinue all other ongoing clinical trials.  

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…